Evidence map›Paper›PMID 30417754›Full record

ArticleJournal of empirical research on human research ethics : JERHRE2018

"Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa.

Siyabonga Thabethe, Catherine Slack, Graham Lindegger, Abigail Wilkinson, Douglas Wassenaar, Philippa Kerr, Linda-Gail Bekker, Kathy Mngadi, Peter A Newman

Abstract read
In one paragraph

Article in Journal of empirical research on human research ethics : JERHRE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Siyabonga Thabethe1 University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Catherine Slack1 University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Graham Lindegger1 University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Abigail Wilkinson1 University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Douglas Wassenaar1 University of KwaZulu-Natal, Pietermaritzburg, South Africa.ORCID 0000-0003-0839-9231
Philippa Kerr1 University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Linda-Gail Bekker2 University of Cape Town, South Africa.
Kathy Mngadi3 Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Peter A Newman5 University of Toronto, Ontario, Canada.

Funding

University of KwaZulu-Natal - CAPRISA HIV/AIDS Clinical Trials UnitUM1AI069469 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI QUARRAISHA ABDOOL KARIM · 2012 to 2026
$36.4M
CIHR THA-118570NIAID NIH HHS UM1 AI069469
6 · The paper itself

Abstract

Trust is a key element of high-quality stakeholder relations, which are themselves essential for the success of HIV vaccine trials. Where trust is absent, community stakeholders might not volunteer to become involved in key trial activities, and potential participants might not volunteer for enrollment. We explored site staff and Community Advisory Board (CAB) members' experiences of trust/mistrust among community members and potential participants. We analyzed 10 focus group discussions with site staff and CAB members at two active South African HIV vaccine trial sites. We report on key characteristics perceived to contribute to the trustworthiness of communicators, as well as factors associated with mistrust. Attributes associated with trustworthy communicators included shared racial identity, competence, and independence (not being "captured"). Key foci for mistrust included explanations about site selection, stored samples, vaccination, and Vaccine Induced Sero-Positivity (VISP). Our findings suggest that community members' trust is not necessarily global, in which trials are trusted or not; rather, it appears fairly nuanced and is impacted by various perceived attributes of communicators and the information they provide. We make recommendations for clinical trial site stakeholders invested in building trust and for future research into trust at these sites.

Indexed as

AIDS VaccinesBiomedical ResearchCommunity ParticipationStakeholder ParticipationTrustCommunicationCommunity-Institutional RelationsFocus GroupsHIV InfectionsHumansResidence CharacteristicsSouth AfricaAIDS VaccinesHIV vaccine trialsinformed consentmistrustresearch ethicsSouth Africastakeholder engagementtrust

Identifiers

PMID30417754
PMCPMC6238163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.